Anemia of chronic disease (ACD) is the second most common type of anemia worldwide, right behind iron deficiency anemia. It develops when a chronic illness — infections, autoimmune conditions, cancer, kidney disease — triggers sustained inflammation that disrupts how your body uses iron. The hallmark paradox: your iron stores are often normal or even elevated, but your body can’t access them to make red blood cells. Hemoglobin typically runs in the 8–12 g/dL range, and most cases are mild to moderate.
If you’ve been diagnosed with a chronic condition and your labs show low hemoglobin with normal or high ferritin, ACD is almost certainly on the differential. It affects an estimated 30–40% of hospitalized patients and is the most common anemia in patients with chronic inflammatory states. The good news: treating the underlying disease often improves the anemia significantly. Here’s what you need to know about the mechanism, diagnosis, and management.
What Exactly Happens in Anemia of Chronic Disease?
The core problem is hepcidin — a liver-produced hormone that acts as the master regulator of iron metabolism. During chronic inflammation, cytokines like interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) drive hepcidin levels way up. Elevated hepcidin does two things that starve your bone marrow of iron:
- Blocks intestinal iron absorption — iron from your diet can’t get into the bloodstream
- Traps iron in macrophages — iron recycled from old red blood cells stays locked in storage instead of being released for new red blood cell production
On top of the iron sequestration, inflammatory cytokines directly suppress erythropoietin (EPO) production in the kidneys and blunt the bone marrow’s response to whatever EPO is produced. The result is a triple hit: restricted iron supply, reduced EPO drive, and a shorter red blood cell lifespan (roughly 80 days instead of the normal 120).
From an evolutionary standpoint, this is actually a defense mechanism. Sequestering iron starves bacteria and other pathogens that need it to replicate. The problem is that in chronic disease states, this “acute phase response” never turns off.
Common Conditions That Cause ACD
- Autoimmune diseases: Rheumatoid arthritis, systemic lupus erythematosus, inflammatory bowel disease
- Chronic infections: HIV, tuberculosis, osteomyelitis, endocarditis, hepatitis C
- Malignancies: Lymphoma, lung cancer, breast cancer, multiple myeloma
- Chronic kidney disease: Especially stages 3–5, where EPO production drops substantially
- Heart failure: Present in up to 50% of patients with chronic HF
Symptoms: Why ACD Often Flies Under the Radar
Most patients with ACD have mild anemia (hemoglobin 9–12 g/dL), and their symptoms blend into the fatigue and malaise of their underlying disease. That’s what makes it tricky — the anemia gets written off as “just part of the illness.”
Symptoms to watch for include persistent fatigue out of proportion to disease activity, exercise intolerance, shortness of breath on exertion, pallor, dizziness, and difficulty concentrating. Heart palpitations or chest tightness can occur when hemoglobin drops below 8 g/dL.
How Doctors Diagnose ACD (and Distinguish It from Iron Deficiency)
This is where it gets clinically important. ACD and iron deficiency anemia (IDA) can look similar on a basic CBC, but the treatment is completely different — giving iron to a pure ACD patient won’t help and may cause harm. Here’s how the lab profiles compare:
| Lab Test | Anemia of Chronic Disease | Iron Deficiency Anemia | ACD + IDA (Mixed) |
|---|---|---|---|
| Hemoglobin | 8–12 g/dL | Often < 10 g/dL | Variable |
| MCV | Normal (80–100 fL) or slightly low | Low (< 80 fL) | Low to normal |
| Serum Iron | Low | Low | Low |
| Ferritin | Normal or high (30–200+ ng/mL) | Low (< 15 ng/mL) | 15–100 ng/mL (ambiguous) |
| TIBC | Low to normal | High (> 400 µg/dL) | Low to normal |
| Transferrin Saturation | 10–20% | < 10% | < 20% |
| CRP / ESR | Elevated | Normal | Elevated |
| Soluble Transferrin Receptor (sTfR) | Normal | Elevated | Elevated |
The single most useful distinguishing test is ferritin. A ferritin below 15 ng/mL is diagnostic of iron deficiency. A ferritin above 100 ng/mL with elevated inflammatory markers points strongly to ACD. The gray zone — ferritin between 15 and 100 — is where the soluble transferrin receptor (sTfR) and the sTfR/log ferritin index become invaluable for identifying coexisting iron deficiency.
Roughly 30–50% of ACD patients also have true concurrent iron deficiency, especially those with GI cancers, inflammatory bowel disease, or chronic kidney disease on dialysis. Missing that overlap means missing a treatable component.
Treatment of Anemia of Chronic Disease
1. Treat the Underlying Disease
This is the most effective strategy. When rheumatoid arthritis goes into remission on biologics, hemoglobin often normalizes. When an infection is cleared, the anemia resolves. Controlling inflammation lowers hepcidin, which unlocks iron stores.
2. Erythropoiesis-Stimulating Agents (ESAs)
For patients with chronic kidney disease and ACD, epoetin alfa or darbepoetin alfa can boost red blood cell production. Target hemoglobin is typically 10–11 g/dL — pushing higher (above 13 g/dL) has been linked to increased cardiovascular risk in clinical trials like CHOIR and TREAT.
3. IV Iron (When Coexisting Iron Deficiency Exists)
Oral iron is poorly absorbed in ACD because hepcidin blocks gut absorption. When true iron deficiency coexists, IV iron (ferric carboxymaltose, iron sucrose) bypasses this block and delivers iron directly to the bloodstream. IV iron should not be given routinely for pure ACD without documented deficiency.
4. Blood Transfusions
Reserved for symptomatic patients with hemoglobin below 7–8 g/dL, or those with active cardiac symptoms. Transfusion is a bridge, not a long-term solution.
5. Emerging Therapies
Hepcidin antagonists and HIF-prolyl hydroxylase inhibitors (like roxadustat) represent promising new approaches that target the root pathophysiology. Roxadustat is already approved in several countries for anemia in CKD and works by stimulating endogenous EPO production and improving iron mobilization.
When to See a Doctor
Talk to your physician if you have a known chronic condition and experience worsening fatigue, exercise intolerance, or any new symptoms of anemia. Specifically, ask for evaluation if:
- Your hemoglobin has been trending downward on serial labs
- You’re fatigued beyond what your underlying disease typically causes
- You’ve been told you’re anemic but “your iron is fine” — this is classic ACD
- You’re on ESAs or iron supplements without clear improvement
Ask your doctor about checking a complete iron panel (not just hemoglobin), CRP, and reticulocyte count to get the full picture.
Frequently Asked Questions
Can anemia of chronic disease be cured?
ACD resolves when the underlying chronic disease is effectively treated or goes into remission. It’s not a standalone disease — it’s a consequence of sustained inflammation. In cases where the chronic illness can’t be cured (like advanced CKD), the anemia can be managed with ESAs and IV iron but may not fully resolve.
Should I take iron supplements for anemia of chronic disease?
Not necessarily. In pure ACD, iron stores are adequate — the problem is iron trapping, not iron deficiency. Taking oral iron supplements won’t help and could contribute to iron overload. However, if testing shows you have both ACD and true iron deficiency (which is common), IV iron may be recommended. Oral iron is typically ineffective in ACD because elevated hepcidin blocks intestinal absorption.
How is anemia of chronic disease different from iron deficiency anemia?
The key difference is ferritin. In iron deficiency anemia, your body is genuinely depleted of iron (ferritin < 15 ng/mL). In ACD, you have plenty of stored iron (ferritin is normal or elevated), but inflammatory signals prevent your body from using it. Serum iron is low in both conditions, which is why ferritin and TIBC are essential for telling them apart.
What hemoglobin level is typical in anemia of chronic disease?
Most patients with ACD have hemoglobin between 8 and 12 g/dL — classified as mild to moderate anemia. It rarely drops below 8 g/dL unless there’s a second contributing factor like concurrent iron deficiency, bleeding, or bone marrow suppression from chemotherapy.
Does anemia of chronic disease show up as microcytic or normocytic?
ACD is typically normocytic and normochromic (normal MCV, normal MCHC). About 20–30% of cases can become mildly microcytic over time, especially with longstanding disease, which further complicates differentiation from iron deficiency anemia. This is another reason a full iron panel — not just a CBC — is needed for accurate diagnosis.
